{"id":"W2593332867","doi":"10.1007/s11899-017-0372-3","title":"New Treatment Strategies for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","year":2017,"lang":"en","type":"review","venue":"Current Hematologic Malignancy Reports","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ponatinib; Medicine; Blinatumomab; Internal medicine; Oncology; Philadelphia chromosome; Dasatinib; Imatinib; Hematology; Chemotherapy; Lymphoblastic Leukemia; Leukemia; Chromosomal translocation; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0002275021,0.002150711,0.007478959,0.0004109638,0.0004584866,0.0002504196,0.0004701571,0.001039124,0.0003436879],"category_scores_gemma":[0.0002433814,0.001494626,0.002737288,0.0002609093,0.0002337214,0.000278991,0.0002196485,0.0004823055,0.0001761119],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.008420918,"about_ca_system_score_gemma":0.02278424,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007199289,"about_ca_topic_score_gemma":0.000009898168,"domain_scores_codex":[0.9927559,0.0001135147,0.002686489,0.002396166,0.0006708063,0.001377053],"domain_scores_gemma":[0.9917719,0.0003655818,0.003859416,0.002970689,0.0002517368,0.0007807105],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009151702,0.0005977214,0.00005195085,0.03880547,0.004338653,0.01773755,0.0001102711,0.00000113837,0.000002505739,0.001061945,0.01092639,0.9262749],"study_design_scores_gemma":[0.002768557,0.001041829,0.00001019019,0.06084457,0.01713732,0.04282511,0.00001569456,0.000009195249,0.000049735,0.001266412,0.8728881,0.001143332],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000468599,0.9851744,0.0007071721,0.00006277907,0.002989222,0.008735799,0.0003386541,0.0003789586,0.001566196],"genre_scores_gemma":[0.0003961046,0.988263,0.0008854234,0.00001389637,0.0009830605,0.002918516,0.003595049,0.000235043,0.002709982],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9251316,"threshold_uncertainty_score":0.9991233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1141424554496944,"score_gpt":0.400997813282527,"score_spread":0.2868553578328326,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}